Type of content created: Blog post

  • Sort by
  • company
In my analysis of the food and beverage market, I’m seeing a transformation in the breadth of how whey protein is being used, and who’s using it. I call it “mainstreamisation”. The English might not be perfect, but I think it’s nevertheless a very fitting description.

Whey protein is rapidly becoming a popular ingredient in clinical applications, thanks to its full complement of essential amino acids as well as several other bioactive constituents that together support treatment regimes for a number of common conditions, including sarcopenia, obesity and malnutrition, post-illness recovery. Such far-reaching potential is seeing rising global demand for whey protein in clinical nutrition, heading for USD 1.5 billion in sales by 2023.

Today, a wide variety of ingredients may appear on the label of infant formulas – a label mothers need to use to determine which product is right for their precious offspring. Alpha-lactalbumin, whey protein hydrolysates, OPN, phospholipids and MFGM are just some of the ingredients being highlighted, giving consumers plenty more to ponder over.